FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018834846> ?p ?o ?g. }

• W2018834846 endingPage "1205" @default.
• W2018834846 startingPage "1198" @default.
• W2018834846 abstract "We aimed to reassess renal amyloidosis in kidney biopsies with a focus on possibly misclassified or unclassified cases and changes in the prevalence of different amyloid types. Two hundred thirty-three kidney biopsies obtained from 231 patients diagnosed with amyloid during the period from 1990 to 2007 years were included in this retrospective study. Amyloid was identified by Congo red staining and polarization microscopy. Immunohistochemical classification was made with antibodies directed against AA amyloid, apolipoprotein A1, fibrinogen, lysozyme, lambda-light chain, kappa-light chain, beta2-microglobulin, transthyretin, and amyloid P-component. Amyloid was present in each biopsy as vascular, tubulo-interstitial and/or glomerular deposits. Immunoglobulin light chain-derived (AL) amyloidosis was most prevalent and diagnosed in 123 (53.2%) patients. It was categorized into AL amyloid of lambda-light chain (ALlambda) [105 (85.4%) patients] and kappa-light chain origin (ALkappa) [10 (8.1%)]. The amyloid deposits of 8 (6.5%) patients were not clearly distinguishable into ALlambda amyloid or ALkappa amyloid and categorized as AL amyloid, not otherwise specified. Reactive systemic amyloid A (AA) amyloidosis was the second most common type and was found in 93 patients (40.3%). Overall 7 patients were found to suffer from fibrinogen A alpha-chain-[amyloid of fibrinogen (AFib); 4 (1.7%) patients], transthyretin-[amyloid of transthyretin (ATTR); 2 (0.9%)], or apolipoprotein A1-derived (AApoAI) amyloidosis [1 (0.4%)]. In 8 patients (3.4%) the amyloid deposits remained unclassifiable. After additional immunostaining and further clinical information the diagnoses of 12 patients (5.1%) were modified (2 ALlambda amyloid, 4 ALkappa amyloid, 1 amyloid unclassified, 3 mixed-type amyloidosis, AA+ATTR, ALlambda+ATTR, and ALkappa+ATTR, 1 AFib, and 1 AApoAI). Although the histologic and immunohistochemical reevaluation confirmed the classifications in 221 (95.7%) patients. Renal amyloidosis is most commonly of ALlambda-origin, followed by AA amyloidosis. AFib amyloidosis was found to be the most prevalent type of hereditary renal amyloidosis, illustrating the necessity of a thorough classification of the amyloid proteins." @default.
• W2018834846 created "2016-06-24" @default.
• W2018834846 creator A5024583139 @default.
• W2018834846 creator A5035782273 @default.
• W2018834846 creator A5036140725 @default.
• W2018834846 creator A5039658349 @default.
• W2018834846 creator A5062696264 @default.
• W2018834846 creator A5068348146 @default.
• W2018834846 date "2009-08-01" @default.
• W2018834846 modified "2023-10-03" @default.
• W2018834846 title "Prevalence and Origin of Amyloid in Kidney Biopsies" @default.
• W2018834846 cites W1502275108 @default.
• W2018834846 cites W1842594908 @default.
• W2018834846 cites W1972755332 @default.
• W2018834846 cites W1975070907 @default.
• W2018834846 cites W1993564924 @default.
• W2018834846 cites W1999770161 @default.
• W2018834846 cites W2000711781 @default.
• W2018834846 cites W2013742067 @default.
• W2018834846 cites W2020377330 @default.
• W2018834846 cites W2033986388 @default.
• W2018834846 cites W2047801833 @default.
• W2018834846 cites W2048734793 @default.
• W2018834846 cites W2049096747 @default.
• W2018834846 cites W2062016694 @default.
• W2018834846 cites W2071134058 @default.
• W2018834846 cites W2083132356 @default.
• W2018834846 cites W2105839764 @default.
• W2018834846 cites W2111338414 @default.
• W2018834846 cites W2122055094 @default.
• W2018834846 cites W2123306712 @default.
• W2018834846 cites W2123828587 @default.
• W2018834846 cites W2124163779 @default.
• W2018834846 cites W2134898483 @default.
• W2018834846 cites W2161648900 @default.
• W2018834846 cites W2167267862 @default.
• W2018834846 cites W4210660926 @default.
• W2018834846 cites W4240572343 @default.
• W2018834846 doi "https://doi.org/10.1097/pas.0b013e3181abdfa7" @default.
• W2018834846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19561448" @default.
• W2018834846 hasPublicationYear "2009" @default.
• W2018834846 type Work @default.
• W2018834846 sameAs 2018834846 @default.
• W2018834846 citedByCount "102" @default.
• W2018834846 countsByYear W20188348462012 @default.
• W2018834846 countsByYear W20188348462013 @default.
• W2018834846 countsByYear W20188348462014 @default.
• W2018834846 countsByYear W20188348462015 @default.
• W2018834846 countsByYear W20188348462016 @default.
• W2018834846 countsByYear W20188348462017 @default.
• W2018834846 countsByYear W20188348462018 @default.
• W2018834846 countsByYear W20188348462019 @default.
• W2018834846 countsByYear W20188348462020 @default.
• W2018834846 countsByYear W20188348462021 @default.
• W2018834846 countsByYear W20188348462022 @default.
• W2018834846 countsByYear W20188348462023 @default.
• W2018834846 crossrefType "journal-article" @default.
• W2018834846 hasAuthorship W2018834846A5024583139 @default.
• W2018834846 hasAuthorship W2018834846A5035782273 @default.
• W2018834846 hasAuthorship W2018834846A5036140725 @default.
• W2018834846 hasAuthorship W2018834846A5039658349 @default.
• W2018834846 hasAuthorship W2018834846A5062696264 @default.
• W2018834846 hasAuthorship W2018834846A5068348146 @default.
• W2018834846 hasConcept C121157162 @default.
• W2018834846 hasConcept C126322002 @default.
• W2018834846 hasConcept C142724271 @default.
• W2018834846 hasConcept C159654299 @default.
• W2018834846 hasConcept C203014093 @default.
• W2018834846 hasConcept C2776914184 @default.
• W2018834846 hasConcept C2777007455 @default.
• W2018834846 hasConcept C2777633098 @default.
• W2018834846 hasConcept C2779036427 @default.
• W2018834846 hasConcept C2779134260 @default.
• W2018834846 hasConcept C2779537928 @default.
• W2018834846 hasConcept C2779951007 @default.
• W2018834846 hasConcept C36394416 @default.
• W2018834846 hasConcept C55359608 @default.
• W2018834846 hasConcept C71924100 @default.
• W2018834846 hasConceptScore W2018834846C121157162 @default.
• W2018834846 hasConceptScore W2018834846C126322002 @default.
• W2018834846 hasConceptScore W2018834846C142724271 @default.
• W2018834846 hasConceptScore W2018834846C159654299 @default.
• W2018834846 hasConceptScore W2018834846C203014093 @default.
• W2018834846 hasConceptScore W2018834846C2776914184 @default.
• W2018834846 hasConceptScore W2018834846C2777007455 @default.
• W2018834846 hasConceptScore W2018834846C2777633098 @default.
• W2018834846 hasConceptScore W2018834846C2779036427 @default.
• W2018834846 hasConceptScore W2018834846C2779134260 @default.
• W2018834846 hasConceptScore W2018834846C2779537928 @default.
• W2018834846 hasConceptScore W2018834846C2779951007 @default.
• W2018834846 hasConceptScore W2018834846C36394416 @default.
• W2018834846 hasConceptScore W2018834846C55359608 @default.
• W2018834846 hasConceptScore W2018834846C71924100 @default.
• W2018834846 hasIssue "8" @default.
• W2018834846 hasLocation W20188348461 @default.
• W2018834846 hasLocation W20188348462 @default.
• W2018834846 hasOpenAccess W2018834846 @default.
• W2018834846 hasPrimaryLocation W20188348461 @default.

• next